Endostar: Clinical Trials

48 trials of Endostar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 unknown, 10 completed, 2 not yet recruiting. 48 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 248Unknown 36, Completed 10, Not yet recruiting 2
Phase 31Unknown 1

Follow Endostar: new trials by email Literature Review of Endostar trials Research Report on Endostar

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLC
Stereotactic Radiation Therapy, Envafolimab, Endostar - Non Small Cell Lung Cancer, Lung Neoplasms
Phase 2Not yet recruitingThe First People's Hospital of Lianyungang612026-10-012026-09-14
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Envafolimab, Recombinant human endostatin, recombinant human adenovirus type 5 - Non-small Cell Lung Cancer
Phase 2Not yet recruitingHenan Cancer Hospital842024-10-082024-10-01
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Envafolimab Injection, Endostar - Gastrointestinal Neoplasms
Phase 2UnknownNanjing First Hospital, Nanjing Medical University162024-02-212024-03-08
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Envafolimab, Endostar, Nab paclitaxel - Advanced Pancreatic Cancer
Phase 2UnknownThe Affiliated Hospital of Xuzhou Medical University202022-04-012022-03-28
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
Envafolimab, Endostar - Lung Neoplasms
Phase 2UnknownThe First People's Hospital of Lianyungang402022-03-012023-06-22
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
Endostar - Nasopharyngeal Carcinoma
Phase 2UnknownJiangxi Provincial Cancer Hospital302021-07-282022-01-04
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Endostar, Toripalimab - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Phase 2UnknownFudan University432020-04-012023-06-22
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
Camrelizumab - Non-small Cell Lung Cancer
Phase 2UnknownPeking University Cancer Hospital & Institute522019-12-312020-03-10
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Radiotherapy, Endostar, Cisplatin - Cervical Cancer
Phase 2UnknownZhejiang Cancer Hospital822019-08-012019-10-10
Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors
second-line chemotherapy, Recombinant human endostatin - Head and Neck Neoplasms
Phase 2UnknownSun Yan532019-07-292020-10-23
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Endostar, Cisplatin, Docetaxel - Nasopharyngeal Carcinoma
Phase 2UnknownJiangsu Cancer Institute & Hospital732019-06-012019-04-30
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
Docetaxel, Nedaplatin, Endostar - Esophageal Cancer
Phase 2UnknownFirst Affiliated Hospital of Guangxi Medical University1862018-11-012018-08-28
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Endostar, Docetaxel, Carboplatin - Lung Cancer
Phase 2UnknownAffiliated Cancer Hospital & Institute of Guangzhou Medical University502018-10-012018-10-17
Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
Endostar, standard SRILI treatment - Radiation Pneumonitis, Endostatin
Phase 2CompletedXinqiao Hospital of Chongqing1262018-09-012024-02-23
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Irinotecan, DDP, Endostar - Esophageal Squamous Cell Carcinoma
Phase 2CompletedFudan University522017-05-042025-07-23
Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma
Endostar, Placebo, AIM regimen / GT regimen - Soft Tissue Sarcoma, Adult, Stage IIB
Phase 2CompletedTianjin Medical University Cancer Institute and Hospital522017-05-012019-12-26
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Endostar, DDP - Cervical Carcinoma
Phase 2CompletedYong Zhang,MD1202017-04-202025-07-29
Endostar First-line Treatment of Advanced NSCLC
Endostar, Gemcitabine, Cisplatin - Non Small Cell Lung Cancer
Phase 2UnknownChina Medical University, China1502017-04-012017-04-21
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
endostar, Placebos, radiotherapy - Non-small Cell Lung Cancer
Phase 2UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology502017-02-212018-08-03
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
recombinant human endostatin - Melanoma
Phase 2UnknownPeking University Cancer Hospital & Institute702016-10-012017-03-29

Showing 20 of 48. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (9)  ·  Nasopharyngeal Carcinoma (6)  ·  Lung Neoplasms (4)  ·  Colorectal Neoplasms (3)  ·  Esophageal Squamous Cell Carcinoma (3)  ·  Esophageal Neoplasms (2)  ·  Lymphoma, T-Cell, Peripheral (2)  ·  Melanoma (2)  ·  Nasopharyngeal Neoplasms (2)  ·  Sarcoma (2)  ·  Uterine Cervical Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)

Sponsors

Fudan University (5)  ·  Zhejiang Cancer Hospital (5)  ·  Jiangsu Simcere Pharmaceutical Co., Ltd. (3)  ·  First Affiliated Hospital of Guangxi Medical University (2)  ·  Peking University Cancer Hospital & Institute (2)  ·  Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd (2)  ·  Simcere Pharmaceutical Co., Ltd (2)  ·  Sun Yat-sen University (2)  ·  The First People's Hospital of Lianyungang (2)  ·  Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1)  ·  China International Medical Foundation (1)  ·  China Medical University, China (1)  ·  China Three Gorges University, Yichang, China (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Henan Cancer Hospital (1)

Countries

China (43)

Top investigators

Xiaodong Jiang, MD (2)  ·  Bin Li (1)  ·  Fei Han, M.D., Ph.D. (1)  ·  Guoliang Jiang, MD (1)  ·  Hanmei Lou, PHD (1)  ·  Hongbo Wu, M.D. (1)  ·  Jian Fang (1)  ·  Jilong Yang, M.D., Ph.D. (1)  ·  Junning Cao, MD (1)  ·  Li Liang, MD (1)  ·  Liming Zhu, MD (1)  ·  Lin Yang, MD (1)  ·  Ming Chen, Doctor (1)  ·  Ming Fan, MD (1)  ·  Peng Yuan, MD (1)

Results publications

PMID 15172975, PMID 22099051, PMID 22209574, PMID 22496834, PMID 22562140, PMID 23670576, PMID 25198661, PMID 25244494, PMID 25497558, PMID 26434908, PMID 27067521, PMID 35380726, PMID 41014160, PMID 41049580